Table 1. Patient and tumour characteristics (n = 81).
| Mean (range) | |
| Age (years) | 69 (37–90) |
| Tumour size (cm) | 2.5 (1.0–4.0) |
| FIGO stage | N (%) |
| I | 25 (31) |
| II | 34 (42) |
| III | 9 (11) |
| IV | 13 (16) |
| Localisation | |
| Upper vagina | 23 (28) |
| Middle vagina | 14 (17) |
| Middle-lower | 2 (3) |
| Lower vagina | 26 (32) |
| Entire length of vagina | 16 (20) |
| Histology | |
| Squamous cell carcinoma | 72 (89) |
| Basaloid | 28 |
| Non-keratinizing | 24 |
| Keratinizing | 9 |
| Verrucous | 2 |
| Adenocarcinoma | 7 (8.5) |
| Other | 2 (2.5) |
| Tumour grade | |
| 1 | 13 (16) |
| 2 | 30 (37) |
| 3 | 27 (33) |
| Unknown | 11 (14) |
| HPV status | (n = 71) |
| Negative | 34 (48) |
| Positive | 37 (52) |
| HPV 16 | 26 |
| Other HPV types | 11 |
| Treatment | |
| EBRT* | 10 (12.5) |
| EBRT+BT | 48 (59) |
| BT** | 13 (16) |
| Other | 10 (12.5) |
*EBRT = external beam radiotherapy,
**BT = vaginal brachytherapy